Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02295293Phase 1Completed
Phase 1, randomised, double-blind trial (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Serum total cholesterol level at 6 weeks, Serum triglyceride level at 6 weeks and 1 more. Started Dec 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02295293.